Prostate Cancer
PROVENGE (sipuleucel-T) in prostate cancer: The first FDA approved therapeutic cancer vaccine - Abstract
April 29, 2011
Drug development for metastatic castration-resistant prostate cancer: Current status and future perspectives - Abstract
April 29, 2011
Emerging novel therapies in the treatment of castrate-resistant prostate cancer - Abstract
April 29, 2011
Biochemical-markers for the diagnosis of bone metastasis: A review in clinical - Abstract
April 29, 2011
Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy - Abstract
April 29, 2011
FDA approves Zytiga for late-stage prostate cancer
April 29, 2011
Listening to Provenge - what a costly cancer treatment says about future Medicare policy - Abstract
April 28, 2011
Value and safety of midazolam anesthesia during transrectal ultrasound-guided prostate biopsy - Abstract
April 28, 2011
Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking - Abstract
April 28, 2011